Benzothiazol-2-ylcarboxylic acids with diverse spacers: A novel class of potent, orally active aldose reductase inhibitors

被引：13

作者：

Aotsuka, T

Abe, N

Fukushima, K

Ashizawa, N

Yoshida, M

机构：

[1] Research and Development Division, GRELAN Pharmaceutical Co., Ltd., Tokyo, 3-4-3, Sakae-cho, Hamura

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(97)00287-4

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The benzothiazol-2-ylcarboxylic acids, with diverse spacers between the carboxy group and the benzothiazole ring, were synthesized and evaluated for their ability to inhibit aldose reductase (AR). The phenylacetic acids 6 which have a less complex structure than that of existing AR inhibitors were found to be highly potent, orally active AR inhibitors. (C) 1997 Elsevier Science Ltd.

引用

页码：1677 / 1682

页数：6

共 16 条

[1] AOTSUKA T, 1994, CHEM PHARM BULL, V42, P1264
[2] Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats
Ashizawa, N
Yoshida, M
Sugiyama, Y
Akaike, N
Ohbayashi, S
Aotsuka, T
Abe, N
Fukushima, K
Matsuura, A
[J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 73 (02) : 133 - 144
[3] SYNTHESIS OF OPTICALLY-ACTIVE BIS(2-OXAZOLINES) - CRYSTAL-STRUCTURE OF A 1,2-BIS(2-OXAZOLINYL)BENZENE.ZNCL2 COMPLEX
BOLM, C
WEICKHARDT, K
ZEHNDER, M
RANFF, T
[J]. CHEMISCHE BERICHTE, 1991, 124 (05) : 1173 - 1180
[4] 1-METHYL-2-PYRROLIDINONE - A WELL-ADAPTED SOLVENT IN THE BENZOTHIAZOLES SYNTHESIS
BREMBILLA, A
ROIZARD, D
LOCHON, P
[J]. SYNTHETIC COMMUNICATIONS, 1990, 20 (21) : 3379 - 3384
[5] GAMEISE DL, 1969, J MED CHEM, V12, P30
[6] HAYMAN S, 1965, J BIOL CHEM, V240, P877
[7] Highly selective aldose reductase inhibitors .1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids
Ishii, A
Kotani, T
Nagaki, Y
Shibayama, Y
Toyomaki, Y
Okukado, N
Ienaga, K
Okamoto, K
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) : 1924 - 1927
[8] ITOH Y, 1992, Drugs of the Future, V17, P31
[9] KADOR PF, 1985, ANNU REV PHARMACOL, V25, P691, DOI 10.1146/annurev.pa.25.040185.003355
[10] THE ROLE OF ALDOSE REDUCTASE IN THE DEVELOPMENT OF DIABETIC COMPLICATIONS
KADOR, PF
[J]. MEDICINAL RESEARCH REVIEWS, 1988, 8 (03) : 325 - 352

← 1 2 →